Loading of peptides into class I molecules occurs in the ER and this process is now known to involve the interaction of several ER proteins, including TAP, gp48 and calreticulin. This grant proposal will define the separate roles of each of these molecules in the ER retention of class I prior to peptide loading and their role in the facilitation of class I assembly.
Three specific aims are proposed: 1) determine whether TAP, calreticulin and/or gp48 is responsible for peptide-induced release of class I from ER retention; 2) define specific interactions between members of the TAP/calreticulin/gp48 complex using mutant class I chains; and 3) define the role of calreticulin using genetic approaches. In this final aim we will genetically disrupt the calreticulin gene to critically assess the role of this known chaperone in class I folding and peptide loading. Basic information obtained from these studies will be fundamental to our understanding of class I antigen presentation and may help in the future design of rational approaches for clinical intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AI001498-03
Application #
6149728
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
1998-02-01
Project End
2002-01-31
Budget Start
2000-02-01
Budget End
2002-01-31
Support Year
3
Fiscal Year
2000
Total Cost
$112,011
Indirect Cost
Name
Washington University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130